Al Carter, executive director of the National Association of Boards of Pharmacy, discusses the report from NABP's work group to consider extending waivers that were issued during the pandemic. He shares how the work group evaluated policy changes into three categories: what should be looked at for permanent consideration in all circumstances, what should be considered during special or unusual public health circumstances, and what should only be considered during declared emergencies.

Hear how the pharmacy association evaluated policy changes, and join the discussion on CLEAR Communities (https://community.clearhq.org/) to share how your organization is evaluating pandemic policy changes moving forward.

Transcript: html (https://www.clearhq.org/page-1860738) or

PDF (http://clearweb.drivehq.com/podcast_transcripts/CLEAR_podcast_episode51_Evaluating_Pandemic_Changes